Vous avez cherché: protejini (Maltais - Anglais)

protejini ta’ annimali biss
animal proteins only

il-pjanti tal-protejini
protein plants

xgħir bħala qamħ, protejini u middlings;
barley as grains, protein and middlings;

kontenut minimu f’sustanzi ta’ protejini ta’ ħalib
minimum content in milk protein substances

sensittivita’ eccesiva ghall-protejini mehudin mill-grieden.
patients with known allergies or hypersensitivity to mouse proteins.

antikorpi huma protejini li jgħarrfu u jeħlu speċifikament ma’ protejini oħra.
antibodies are proteins that specifically recognise and bind to other proteins.

reazzjoni anafilattika hija possibli meta jintuzaw protejini tal-grieden fil-bnedmin.
anaphylactic and other hypersensitivity reactions are possible whenever mouse protein materials are administered to patients.

lacosamide jeħel mal-protejini tad-demm b’rata baxxa ta’ 15%.
lacosamide has a low protein binding of less than 15%.

pazjenti li inghatalhom qabel dawn il-protejini ghandhom possibilita’ akbar li jizviluppaw hama.
patients who have previously received murine monoclonal antibody products are more likely to have hama.

brivaracetam huwa marbut b’mod dgħajjef (≤20 %) mal-protejini fil-plażma.
brivaracetam is weakly bound (≤ 20 %) to plasma proteins.

għalhekk mhux probabli li jkun hemm effetti klinikament relevanti ma’ mediċini oħra permezz ta’ kompetizzjoni għal postijiet fejn jeħlu l-protejini.
therefore, clinically relevant interactions with other drugs through competition for protein binding sites are considered unlikely.

f’konċentrazzjonijiet terapewtiċi, aripiprazole u dehydro-aripiprazole jintrabtu b’iktar minn 99 % mal-protejini tad-demm, u jintrabtu l- aktar ma’ l-albumina.
at therapeutic concentrations, aripiprazole and dehydro-aripiprazole are greater than 99 % bound to serum proteins, binding primarily to albumin.